Celgene to Use Cypher Genomics’ Data Analytics in Drug Development
May 20, 2015, 00:00 AM
by
Michael Croft
Xconomy | Under a collaboration announced today,
San Diego-based Cypher Genomics said it would use its biomarker
discovery service to help New Jersey's Celgene identify key genetic
variants among patients who respond well to specific drugs.
May 20, 2015 | Under a collaboration announced today, San Diego-based Cypher Genomics said it would use its biomarker discovery service to help New Jersey's Celgene identify key genetic variants among patients who respond well to specific drugs. Xconomy